Editorial review
Educational content is reviewed for source quality, clinical boundaries, and readability. It is not medical advice; confirm care decisions with a licensed clinician.
For depression, a commonly studied intravenous ketamine course is six treatments over about 2-3 weeks, often two or three times per week. The answer to how many ketamine treatments for depression is not the same for every person, though. Clinicians typically look at symptom change across the initial series, then use follow-up symptom tracking to decide whether treatment spacing, maintenance care, or a different approach makes sense.
Ketamine is used in several clinical contexts, and treatment plans can differ by route, dose, diagnosis, medical history, and supervising clinician. This guide describes commonly reported intravenous infusion patterns, not a personal treatment plan.
Quick Answer
A commonly studied initial intravenous ketamine series for depression is six treatments delivered over 2-3 weeks. People who benefit may later receive maintenance treatments, often spaced weeks apart, based on when symptoms return and how their clinician assesses safety and response. A lack of early improvement does not always determine the final response, which is why the full planned series is often reviewed before drawing conclusions.
The initial treatment course
Six infusions over 2-3 weeks is a frequently used starting framework in published repeated-dose research and clinical practice. According to a 2013 study indexed by PubMed, participants with treatment-resistant depression received six intravenous ketamine infusions over 12 days.
Response can emerge at different points in the series. Some people report a meaningful change after one or two sessions, while others do not notice a clear change until later. A clinician may track mood, functioning, sleep, side effects, and suicidal thoughts rather than relying on one good or difficult day after treatment.
The National Institute of Mental Health describes depression as a condition that can affect mood, thinking, and daily functioning, and it advises working with a health care provider on treatment options. Read its depression overview for general information about diagnosis and care.
If symptoms do not improve after a planned initial series, the appropriate next step is a clinical review. That discussion may include whether the diagnosis, dose, route, concurrent medicines, expectations, or treatment strategy need reassessment. It should not be assumed that simply continuing the same schedule will help.
What to track during an initial series
- Record baseline symptoms before the first treatment, including mood, sleep, anxiety, and ability to complete usual activities.
- Use the same validated measure, such as the PHQ-9 when a clinician recommends it, at regular follow-ups.
- Note when any relief begins, how long it lasts, and whether functioning changes with it.
- Bring an updated medication and substance-use list to follow-up visits so potential interactions can be reviewed.
- Seek urgent help or contact the treating team promptly if suicidal thoughts worsen or safety feels uncertain.
Maintenance treatments are based on the return of symptoms
Ketamine’s antidepressant effect may not last indefinitely after an initial course. For people who respond, clinicians may discuss maintenance treatment and adjust the interval according to symptom recurrence, side effects, practical burden, and the rest of the treatment plan.
Reported maintenance schedules often range from every 2 weeks to every 6 weeks, but this is not a fixed rule. Someone whose symptoms return quickly may need a closer review than someone whose benefit persists longer. The useful question is not only “How long since the last treatment?” but also “What changed in symptoms and daily life during that interval?”
For a closer look at timing, see how far apart low-dose ketamine treatments may be spaced. If you are trying to separate short-term effects from sustained changethis guide to how long ketamine effects last can help frame that conversation.
Questions to bring to follow-up
A follow-up visit is where treatment count becomes a decision rather than a calendar exercise. Ask what measure is being used to judge response, what degree of change would support maintenance treatment, and what would prompt a change in plan. Ask how other treatments, including psychotherapy and prescribed antidepressants, fit into the plan.
Also ask which symptoms or side effects should trigger a call before the next session. Medication review matters because some medicines and substances can affect safety or care planning. See the guide to ketamine drug interactions for general discussion points to raise with a clinician.
Compare low-dose options
Review routes, dosing discussions, and alternatives before speaking with a clinician.
Compare optionsKey Takeaway
Six intravenous treatments over 2-3 weeks is a common research-based starting point for depression, but the right number and spacing depend on documented response, tolerability, and clinical follow-up.
Keep Reading Dosing Guides
Review practical low-dose ketamine dosing and follow-up guides before your next treatment discussion.
Frequently Asked Questions
Share
Related Reading
Contact Low Dose Ketamine
Send corrections, provider questions, or advertising inquiries.